全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

Epidemiological and Histopathological Profile of Prostate Cancer: A Retrospective Study in the Pathology Department of the University Clinics of Kinshasa

DOI: 10.4236/jct.2024.156023, PP. 239-249

Keywords: Prostate, Gleason Score, Democratic Republic of Congo

Full-Text   Cite this paper   Add to My Lib

Abstract:

Background: Prostate cancer, the most common male cancer, represents a real public health problem in terms of its frequency and severity in different countries around the world. It disproportionately affects people of African descent wherever they live in the world [1]. To the best of our knowledge, its extent and particularities in the African environment are not well known. Objective: To determine the epidemiological and histopathological profile of prostate cancer in the CUK anatomopathology department. Methodology: This is a retrospective study conducted at the University Clinics of Kinshasa Anapathology Department from January 1, 2015 to December 31, 2022, a period of 8 years. Word processing and tables were entered using the Hp brand computer, with Microsoft Office WORD 2016 software. Data analysis was performed with SPSS version 22.0 software. Results were presented in tables and figures. Results: Prostate was diagnosed in 132 cases, i.e. 1.58% of all CUK laboratory analyses and 8% of cancers diagnosed. The age group most affected was 66-75 years, i.e. 59% of all subjects. Adenocarcinoma was the most frequent histological type, and biopsy dominated in 111 cases (84.1%). Conclusion: Prostate cancer is a real public health problem. Worldwide, and in the Democratic Republic of Congo, it is the most frequently diagnosed cancer in men, and the leading cause of cancer-related death in men. In the DRC, because of the delay in consulting our patients and the weakness of systematic screening, patients are seen at an advanced stage of the disease. Treatment is multidisciplinary, involving surgery, radiotherapy and chemotherapy (including targeted therapies). Patient awareness and screening campaigns will help to considerably reduce the delay in diagnosis and the morbidity and mortality associated with prostate cancer.

References

[1]  Punga-Maole, A.M., Moningo, D.M., Kayembe, P.K., Tshikuela, M.L. and Kabongo, J.M. (2008) Study of Prostate Cancer Screening in a Population of Employees of a Company in Kinshasa, Democratic Republic of Congo. Detection Rate and Nutritional and Geographical Risk Factors. Progrès en Urologie, 18, 512-518.
https://doi.org/10.1016/j.purol.2008.04.009
[2]  International Agency for Research on Cancer, GLOBOCAN 2022.
https://gco.iarc.who.int/media/globocan/factsheets/populations/900-world-fact-sheet.pdf
[3]  Dimitri, M., Collins, P.W., Daniela Starmann, D., Savi, S., Claire Ross, C., Adams, M. and Marco Narducci, M. (2023) The World Foundation of Urology-C.F. 06477631003.
[4]  Ferlay, J., Soerjomataram, I., Ervik, M., Dikshit, R., Eser, S., Mathers, C., Rebelo, M., Parkin, D.M., Forman, D. and Bray, F. (2013) GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldide: IARC Cancer Base No.11. International Journal of Cancer, 5, 359-386.
[5]  Chu, L.W., Ritchey, J., Devesa, S.S., Quraishi, S.M., Zhang, H.M. and Hsing, A.W. (2011) Prostate Cancer Incidence Rates in Africa. Prostate Cancer, 2011, Article ID 947870.
https://doi.org/10.1155/2011/947870
[6]  Halidou, M., Kodo, A., Diongolé, H., Zakou, A.R.H., Magagi, I. and Amadou, S. (2024) Le Cancer de la Prostate au Niger: Aspects Epidémiologiques Cliniques et Histologiques à l’Hôpital National de Zinder. Health Sciences and Disease, 23.
[7]  Kambere, S.R. and Kabongo, M.J.M. (2013) Epidemiological Profile and Histologic Based Outcome of Prostatic Cancer in Congolese Patient Following Gleason’s Classification.
[8]  Ngandu, T.J., Punga, M.A., Kabongo, M.J.M., Lebwaze, M.B., Moningo, D. et al. (2015) Prévalence du cancer de la prostate a Mbujimayi en République Démocratique du Congo. Revue Medicale des Grands Lacs, 4, 106-121.
https://www.researchgate.net/publication/293654251_Prevalence_du_cancer_de_la_prostate_a_Mbujimayi_en_Republique_Democratique_du_Congo
[9]  Ngandu, T.J., Punga, M.A., Kabongo, M.J.M., Lebwaze, M.B., Moningo, D. et al. (2015) Facteurs de risque de cancer de la prostate à Mbujimayi. Revue Medicale des Grands Lacs, 4, 195-204.
https://www.researchgate.net/publication/293452488_Facteurs_de_risque_de_cancer_de_la_prostate_a_Mbujimayi
[10]  Ngandu, T.J., Punga, M.A., Kabongo, M.J.M., Lebwaze, M.B., Moningo, D. et al. (2015) PSA Value in Prostate Cancer Diagnosis.
[11]  Ngandu, T.J., Punga, M.A., Kabongo, M.J.M., Lebwaze, M.B., Moningo, D. et al. (2015) Prostate Cancer Histopronostic Caracteristiques.
[12]  Lomba, D.O. (2016) Profil Anatomoclinique du cancer de la prostate à l’IME-KIMPESE, Travail de fin d'études, Faculté de Médecine Humaine, Université Protestante de Kimpese, 2015-2016.
[13]  Ouattara, A. (2012) Epidemiology of Utological Cancers at the Hubert Koutoukou Maga National University Hospital Cotonou, Benin. Review of about 158 Cases of Urologic Cancers. Progrès en Urologie, 22, 261-265.
https://doi.org/10.1016/j.purol.2011.12.003

Full-Text

comments powered by Disqus

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133